Mostrar el registro sencillo del ítem

dc.contributor.advisorIkeda, Maria Letícia Rodrigues
dc.contributor.authorDal Bó, Andréa Gurgel Batista Leite
dc.date.accessioned2023-11-27T11:57:28Z
dc.date.accessioned2024-02-28T18:58:35Z
dc.date.available2023-11-27T11:57:28Z
dc.date.available2024-02-28T18:58:35Z
dc.date.issued2023-08-29
dc.identifier.urihttps://hdl.handle.net/20.500.12032/126656
dc.description.abstractThis Collective Health doctoral thesis of the Collective Health Graduate Program at the University of Vale do Rio dos Sinos – UNISINOS – aimed to evaluate the prognostic indicators in critically ill patients with SARS-CoV-2 infection, hospitalized in an Intensive Care Unit (ICU) at Virvi Ramos Hospital in Caxias do Sul/RS, treated or not with convalescent plasma for COVID-19 (PCC). In addition, a survival analysis was also performed. This thesis is composed of two articles. The first makes a mini-review on the early use of convalescent plasma for COVID-19 as a potential low-cost treatment for patients in risk groups, especially in countries with little access to antiviral therapies and vaccines. The second article is a retrospective, propensity-matched cohort study of patients hospitalized in the ICU for severe COVID-19 who received PCC transfusion plus standard care, compared with controls who received standard care only. The primary outcome was mortality within 30 days of admission to the ICU. A total of 124 patients (62 in each group) were included. The median age for the entire series was 66 years (IQR: 55-73), and 89 (55.6%) were men. The median time from symptom onset to PCC was 10 days (IQR: 8-13 days). In total, 51 (41.1%) died within 30 days of admission. PCC transfusion was not independently associated with lower 30-day mortality (OR: 0.52, 95% CI: 0.23–1.16; p = 0.11) and also had no impact on mechanical ventilation or same time.en
dc.description.sponsorshipCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorpt_BR
dc.languagept_BRpt_BR
dc.publisherUniversidade do Vale do Rio dos Sinospt_BR
dc.rightsopenAccesspt_BR
dc.subjectPlasma convalescentept_BR
dc.subjectConvalescent plasmaen
dc.titleUso de plasma convalescente em pacientes com COVID-19pt_BR
dc.typeTesept_BR


Ficheros en el ítem

FicherosTamañoFormatoVer
Andrea Dal Bó_PROTEGIDO.pdf1.466Mbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem


© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP